CKDinform: Early Detection and Prevention

Irving, TX US
April 2, 2016

This 3-hour CME/CE symposium focuses on the unique role that primary care practitioners (PCPs) play in managing CKD patients. The burden of CKD to the population, modifiable CKD risk factors, screening methods, and interpretation of test results will be discussed. The use of GFR and albuminuria in CKD detection will also be covered. Evidence-based treatment recommendations and management plans for CKD will be presented. This program will also address the need for timely referral to nephrologists, in addition to the importance of patient education and counseling. Case-based questions are also included.


Once you are logged in the "ADD TO CART" button can be found at the bottom of this webpage.

Target Audience

  • Physicians (primary care, cardiologists, endocrinologists)
  • Physician Assistants
  • Nurse Practitioners
  • Nurses
  • Other clinicians who care for people with CKD
Learning Objectives:
  • Identify timely testing and intervention strategies in patients at-risk for chronic kidney disease (CKD).
  • Explain appropriate clinical measures to manage risk and increase patient safety in CKD.
  • Recognize co-management and referral of patients to nephrology specialists, when appropriate, in order to improve outcomes in CKD.
  • Describe suitable screening tools, such as GFR and ACR for proper utilization in clinical practice related to the diagnosis and monitoring of CKD.
  • Define and classify CKD, based on GFR and albuminuria categories, in order to guide appropriate treatment approaches.
  • Recognize evidence-based management strategies that will help delay CKD progression in at-risk patients and improve outcomes.
  • Describe treatment options for renal replacement therapy to improve awareness and understanding.
  • Explain evidence-based strategies to manage patients with kidney failure in need of renal replacement therapy to improve outcomes.
  • Discuss management of patients receiving dialysis or living with a kidney transplant, from a primary care perspective.
Program Agenda:
7:15am - 8:00amContinental Breakfast
7:45am - 8:00amWelcome
Alexander Liang, MD
8:00am - 8:45amKeynote - Ebola - A complex Viral Illness
Bruce Wall, MD
8:45am - 9:45amCKDinform: Early Detection and Prevention
A Primary Care Approach to CKD Management

Daniel Richey, DO - Dallas Nephrology Associates
9:45am - 10:00amBreak
10:00am - 11:00amCKDinform: Early Detection and Prevention
A PCP’s Guide to CKD Detection and Delaying Progression

Archana Rao, MD - Dallas Nephrology Associates
11:00am - 12:00pmCKDinform: Early Detection and Prevention
Renal Replacement Therapy: What the PCP Needs to Know

Arthi Rajagopal, MD - Dallas Nephrology Associates
12:00pm - 12:30pmQuestions & Answers / Closing Remarks
CME/CE Information:


The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit(s)™.

Family Physician

Application for CME credit has been filed with the American Academy of Family Physicians.  Determination of credit is pending.

Physician Assistant

AAPA accepts certificates of participation for educational activities certified for Category I credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner

This program is pending approval with the American Association of Nurse Practitioners.


The National Kidney Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.


Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest policy. 

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.


The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patient, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Method of Participation:

Participants will attend the live symposia and submit an online evaluation.  Participants will be able to download their certificate upon completion of the online evaluation.  Credits will be awarded based on sessions attended.

Supported, in part, by educational grants from AMAG Pharmaceuticals, Inc., AstraZeneca, Mallinckrodt Pharmaceuticals, and Sanofi US.

Thank you to our sponsor: Dallas Nephrology Associates

This activity may receive support, in part, by educational grants from industry.  At this time a complete listing of commercial supporters is not available.  Appropriate acknowledgement will be given to all supporters at the time of the educational activity.


Course summary
Available credit: 
  • 3.00 AAFP Prescribed Credits
  • 3.00 AANP Contact Hours
  • 0.53 AANP Pharmacology
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Category I Credit for Physician Assistants
  • 3.00 ANCC Nurse Contact Hours
  • 0.53 ANCC Pharmacology
  • 3.00 Attendance
Course opens: 
Course expires: 
Event starts: 
04/02/2016 - 7:15am
Event ends: 
04/02/2016 - 12:30pm
Omni Hotel at Las Colinas - Mandalay Ballroom
221 East Las Colinas Boulevard
Irving, TX 75039
United States

Available Credit

  • 3.00 AAFP Prescribed Credits
  • 3.00 AANP Contact Hours
  • 0.53 AANP Pharmacology
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Category I Credit for Physician Assistants
  • 3.00 ANCC Nurse Contact Hours
  • 0.53 ANCC Pharmacology
  • 3.00 Attendance


Please login or register for a PERC account to take this course.